• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促卵泡激素分泌型垂体腺瘤:经蝶窦手术后腺瘤大小的缩小与激素分泌亢进减轻的相关性

Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.

作者信息

Harris R I, Schatz N J, Gennarelli T, Savino P J, Cobbs W H, Snyder P J

出版信息

J Clin Endocrinol Metab. 1983 Jun;56(6):1288-93. doi: 10.1210/jcem-56-6-1288.

DOI:10.1210/jcem-56-6-1288
PMID:6404924
Abstract

Ten men who had FSH-secreting pituitary adenomas were evaluated before and 4-6 weeks after transsphenoidal surgery to determine whether reduction of adenoma mass would ameliorate the hormonal abnormalities associated with these adenomas. Nine of the 10 men exhibited marked reduction in adenoma size, as judged by computerized tomography, an 7 had improvement in vision. The same 9 men also had decreases in basal serum FSH concentrations to within the normal range after surgery. The 1 man who had no reduction in adenoma size by computed tomographic scan and whose serum FSH concentration did not decrease to normal after surgery was also the only patient whose abnormal FSH and LH responses to TRH did not improve after surgery. Another man, who had a reduction in adenoma size and serum FSH concentration after surgery, subsequently had regrowth of the adenoma and concomitant resurgence of the FSH concentration. Two men had increases in their serum testosterone concentrations from subnormal to well within the normal range after surgery, suggesting that gonadotroph cell adenomas may impair LH secretion from normal gonadotroph cells. We conclude that the correlation of reduction in adenoma size with reduction in hormonal hypersecretion after surgery suggests that the hormonal hypersecretion is a direct consequence of the adenomatous tissue.

摘要

对10例患有促卵泡激素(FSH)分泌型垂体腺瘤的男性患者在经蝶窦手术前及术后4 - 6周进行评估,以确定腺瘤体积的缩小是否会改善与这些腺瘤相关的激素异常情况。通过计算机断层扫描判断,10例患者中有9例腺瘤大小显著减小,7例视力有所改善。同样这9例患者术后基础血清FSH浓度也降至正常范围。经计算机断层扫描腺瘤大小未减小且术后血清FSH浓度未降至正常的那1例患者,也是术后FSH和LH对促甲状腺激素释放激素(TRH)异常反应未改善的唯一患者。另1例患者术后腺瘤大小及血清FSH浓度降低,但随后腺瘤复发且FSH浓度随之再度升高。2例患者术后血清睾酮浓度从低于正常水平升至正常范围,提示促性腺激素细胞腺瘤可能会损害正常促性腺激素细胞的LH分泌。我们得出结论,术后腺瘤大小的减小与激素分泌过多的减少之间的相关性表明,激素分泌过多是腺瘤组织的直接后果。

相似文献

1
Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.促卵泡激素分泌型垂体腺瘤:经蝶窦手术后腺瘤大小的缩小与激素分泌亢进减轻的相关性
J Clin Endocrinol Metab. 1983 Jun;56(6):1288-93. doi: 10.1210/jcem-56-6-1288.
2
Gonadotroph cell adenomas of the pituitary.垂体促性腺激素细胞腺瘤
Endocr Rev. 1985 Fall;6(4):552-63. doi: 10.1210/edrv-6-4-552.
3
Gonadotroph cell pituitary adenomas.垂体促性腺激素细胞腺瘤。
Endocrinol Metab Clin North Am. 1987 Sep;16(3):755-64.
4
Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.通过重复给予促性腺激素释放激素拮抗剂抑制促性腺激素腺瘤分泌促卵泡激素
J Clin Endocrinol Metab. 1990 Jul;71(1):92-7. doi: 10.1210/jcem-71-1-92.
5
Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion.促甲状腺激素释放激素会引发患有垂体腺瘤且促卵泡激素(FSH)分泌过多的男性出现异常的促卵泡激素(FSH)和促黄体生成素反应。
J Clin Endocrinol Metab. 1980 Oct;51(4):744-8. doi: 10.1210/jcem-51-4-744.
6
Gonadotroph adenoma with secondary hypersecretion of testosterone.促性腺激素腺瘤伴睾丸酮的继发性分泌过多。
World Neurosurg. 2013 Dec;80(6):900.e7-11. doi: 10.1016/j.wneu.2012.11.069. Epub 2012 Nov 28.
7
Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.促性腺激素细胞腺瘤在体内和体外培养时激素分泌行为的比较。
J Clin Endocrinol Metab. 1985 Dec;61(6):1061-5. doi: 10.1210/jcem-61-6-1061.
8
Follicle-stimulating hormone-secreting pituitary tumor with concomitant elevation of serum alpha-subunit levels.伴有血清α亚基水平升高的促卵泡激素分泌型垂体瘤。
J Clin Endocrinol Metab. 1984 May;58(5):937-41. doi: 10.1210/jcem-58-5-937.
9
Recognition of gonadotroph adenomas in women.女性促性腺激素腺瘤的识别
N Engl J Med. 1991 Feb 28;324(9):589-94. doi: 10.1056/NEJM199102283240904.
10
Follicle-stimulating hormone-secreting pituitary adenomas.分泌促卵泡激素的垂体腺瘤
J Clin Endocrinol Metab. 1985 Sep;61(3):525-8. doi: 10.1210/jcem-61-3-525.

引用本文的文献

1
Updating the Landscape for Functioning Gonadotroph Tumors.更新功能性腺瘤的现状。
Medicina (Kaunas). 2022 Aug 8;58(8):1071. doi: 10.3390/medicina58081071.
2
Cabergoline modulation of alpha-subunits and FSH secretion in a gonadotroph adenoma.卡麦角林对促性腺激素腺瘤中α亚基和促卵泡激素分泌的调节作用
J Endocrinol Invest. 2000 Jul-Aug;23(7):463-6. doi: 10.1007/BF03343756.
3
Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
促甲状腺激素释放激素试验、SMS 201-995及溴隐亭在促性腺激素分泌型垂体腺瘤诊断和治疗中的应用价值。
J Endocrinol Invest. 1994 Feb;17(2):99-104. doi: 10.1007/BF03347693.
4
Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.一名分泌促卵泡生成素的垂体腺瘤患者使用长效溴隐亭(Parlodel-LAR)的急性效应及对溴隐亭长期治疗的反应
J Endocrinol Invest. 1991 Feb;14(2):135-8. doi: 10.1007/BF03350285.